We are live on ! Find out more
CERO

CERo Therapeutics
CERO

Delisted

CERO was delisted on the 30th of October, 2025.

Back to rankings

14 hedge funds and large institutions have $320K invested in CERo Therapeutics in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

27% more funds holding

Funds holding: 11 → 14 (+3)

0% less ownership

Funds ownership: 0.01% → 0% (-0%)

43% less capital invested

Capital invested by funds: $557K → $320K (-$237K)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
5
Increased
5
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APP
Avantax Planning Partners
Iowa
+$195K
2
SM
Selkirk Management
New Jersey
+$18.6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$16.8K
4
HF
HRT Financial
New York
+$10.4K
5
XT
XTX Topco
Cayman Islands
+$8.53K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$5.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVM
1
Arch Venture Management
Illinois
$135K – – –
APP
2
Avantax Planning Partners
Iowa
$127K +$195K +641 +1,603%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$14.7K +$16.8K +55 +229%
SM
4
Selkirk Management
New Jersey
$11.3K +$18.6K +61 New
HF
5
HRT Financial
New York
$7K +$10.4K +34 +567%
FLC
6
Fifth Lane Capital
Texas
$6.89K – – –
Jane Street
7
Jane Street
New York
$5.32K +$3.66K +12 +75%
XT
8
XTX Topco
Cayman Islands
$5.27K +$8.53K +28 New
FIA
9
FNY Investment Advisers
New York
$2K +$3.05K +10 +333%
SG
10
StoneX Group
New York
$1.55K +$2.44K +8 New
Corient Private Wealth
11
Corient Private Wealth
Florida
$1.4K – – –
BC
12
Birchview Capital
Vermont
$1.21K – – –
JF
13
Jump Financial
Illinois
$1.11K +$1.83K +6 New
TRCT
14
Tower Research Capital (TRC)
New York
$462 +$609 +2 New
Osaic Holdings
15
Osaic Holdings
Arizona
$36 – – –
PA
16
Pineridge Advisors
Missouri
$28 – – –
Bank of America
17
Bank of America
North Carolina
$22 – – –
Two Sigma Investments
18
Two Sigma Investments
New York
– -$5.41K -9 Closed

CERO Hedge Fund Activity: Q3 2024 in Review

14 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics (CERO) for Q3 2024, worth a combined $320K — down 43% from $557K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CERO positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Avantax Planning Partners, adding an estimated $195K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $5.41K sold.

  • 14 institutional investors held CERo Therapeutics (CERO) as of Q3 2024, up from 11 in Q2 2024.
  • Funds reported $320K of CERo Therapeutics stock for Q3 2024, down 43% quarter-over-quarter.
  • 5 funds opened new CERo Therapeutics positions in Q3 2024 and 1 closed out, a net change of +4 holders.
  • The largest CERo Therapeutics buyer in Q3 2024 was Avantax Planning Partners, an estimated $195K added.
  • The largest CERo Therapeutics seller in Q3 2024 was Two Sigma Investments, an estimated $5.41K sold.

Based on aggregated 13F filings for Q3 2024.